Théberge Emilie T, Burden Elizabeth, Leung Katrina, Parvand Mahraz, Prodan-Bhalla Natasha, Humphries Karin H, Sedlak Tara L
University of British Columbia, Vancouver, British Columbia, Canada.
Vancouver Coastal Health, Vancouver, British Columbia, Canada.
CJC Open. 2024 Sep 3;6(12):1462-1475. doi: 10.1016/j.cjco.2024.08.013. eCollection 2024 Dec.
Myocardial infarction with no obstructive coronary arteries (MINOCA), and ischemia with no obstructive coronary arteries (INOCA), are female-predominant conditions; clinical trials are lacking to guide medical management for the common underlying vasomotor etiologies. Data on long-term outcomes of (M)INOCA patients following attendance at a women's heart centre (WHC) are lacking.
Women diagnosed with MINOCA (n = 51) or INOCA (n = 112) were prospectively followed for 3 years at the Leslie Diamond WHC (LDWHC) in Vancouver. Baseline characteristics, diagnoses, chest-pain type, major adverse cardiac events, hospital encounters, medications, and Seattle Angina Questionnaire (SAQ) responses were compared between the baseline and 3-year timepoints. The χ test was used to compare categorical variables; the Student test was used for continuous variables.
MINOCA patients had significantly more nonexertional chest pain and more diagnoses of vasospasm than did INOCA patients, who had more exertional chest pain and more diagnoses of coronary microvascular dysfunction. Following the baseline timepoint, both groups had significant reductions in cardiovascular emergency room visits, with INOCA patients also experiencing fewer cardiovascular hospitalizations. At 3 years, the most commonly prescribed medications were calcium-channel blockers, long-acting nitrates, and beta-blockers, with MINOCA patients having more acetylsalicylic acid use, and INOCA patients having more short-acting nitrate and ranolazine prescriptions. Both groups observed significant improvements in SAQ scores, with greater improvements observed in INOCA patients. Patients with depression or who were prescribed ranolazine at 3 years had worse SAQ scores at baseline.
The 3-year outcomes of (M)INOCA patients indicate that the LDWHC's comprehensive care model effectively improves diagnostic clarity, reduces the number of hospital encounters, optimizes medication management, and improves self-reported patient well-being.
无阻塞性冠状动脉的心肌梗死(MINOCA)和无阻塞性冠状动脉的缺血(INOCA)是以女性为主的病症;缺乏临床试验来指导针对常见潜在血管舒缩病因的药物治疗。目前尚无关于(M)INOCA患者在女性心脏中心(WHC)就诊后的长期预后数据。
在温哥华的莱斯利·戴蒙德女性心脏中心(LDWHC),对诊断为MINOCA(n = 51)或INOCA(n = 112)的女性进行了为期3年的前瞻性随访。比较基线和3年时间点之间的基线特征、诊断、胸痛类型、主要不良心脏事件、住院情况、药物治疗以及西雅图心绞痛问卷(SAQ)的回答。采用χ检验比较分类变量;采用学生t检验比较连续变量。
与INOCA患者相比,MINOCA患者有更多的非劳力性胸痛和更多的血管痉挛诊断,而INOCA患者有更多的劳力性胸痛和更多的冠状动脉微血管功能障碍诊断。在基线时间点之后,两组的心血管急诊就诊次数均显著减少,INOCA患者的心血管住院次数也较少。在3年时,最常用的药物是钙通道阻滞剂、长效硝酸盐和β受体阻滞剂,MINOCA患者使用阿司匹林更多,INOCA患者使用短效硝酸盐和雷诺嗪的处方更多。两组的SAQ评分均有显著改善,INOCA患者的改善更为明显。在3年时患有抑郁症或服用雷诺嗪的患者在基线时的SAQ评分较差。
(M)INOCA患者的3年预后表明,LDWHC的综合护理模式有效提高了诊断清晰度,减少了住院次数,优化了药物管理,并改善了患者自我报告的健康状况。